Synthace raises a £7.3m Series A to bring open source to biotech



Synthace, a UK startup using open source technology to make process in biotechnology move faster, has raises a £7.3m Series A round. New investors White Cloud Capital, Amadeus Capital Partners and Eleven Two Capital participated alongside existing investors that included Sofinnova Partners, SOSV and Bioeconomy Capital.

The Company’s Antha operating system replaces processes which are currently done, almost, by hand.

CEO Tim Fell says the company came out of the desire to better…

Read the entire article at the source link…


We're happy to share this resource that we found. The content displayed on this page is property of it's original author and/or their organization.

Leave a Reply